Rapid acceleration of diagnotics (RADX) advanced technologies platform
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92020C00006
- Awardee
-
Helix Opco LLC UEI EVK2ALWXCT21
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $45,873,411
Award facts
- Contract value 100% obligated
- $45,873,411.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Mateo, CA 94401, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Close Out | -$9,682 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Supplemental Agreement for work within scope | $1,983,503 | |
| Additional Work (new agreement, FAR part 6 applies) | $4,812,800 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $700,000 | |
| Supplemental Agreement for work within scope | $4,965,290 | |
| Change Order | $0 | |
| Definitize Letter Contract | $20,399,000 | |
| Other Administrative Action | $0 | |
| Original award | $13,022,500 |
Show all 14
About this award
Helix Opco, LLC was awarded a definitive contract valued at $45.9 million by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to support the Rapid Acceleration of Diagnostics (RADX) Advanced Technologies Platform. The firm fixed price contract runs from July 2020 through October 2022 and calls for Helix Opco to provide services in support of the RADX program, which aims to accelerate the development, commercialization, and implementation of novel, portable technologies for point-of-care diagnosis of heart, lung, blood, and sleep disorders. As the prime contractor, Helix Opco will leverage major subcontractors to fulfill the program's objectives over the next two years from its place of performance in San Mateo, California.
Quick answers
Who was awarded contract 75N92020C00006?
75N92020C00006 was awarded to Helix Opco LLC by National Heart Lung and Blood Institute (National Institutes of Health) on July 30, 2020.
How much is contract 75N92020C00006 worth?
The government has obligated $45,873,411 on 75N92020C00006.
Was contract 75N92020C00006 competed?
The extent of competition for 75N92020C00006 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award